Pfizer Inc. shares ticked up modestly Tuesday as investors weighed fresh positive oncology data against the pharmaceutical ...

In undertaking this survey, researchers aimed to assess the limitations of ctDNA testing in the clinic, as well as areas in which it is considered clinically meaningful.

CHENGDU, China and JANESVILLE, Wis., March 26, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu, China), a global radiopharmaceutical CRDMO, today announced the execution of a Master Radioisotope ...

Novel agent outperforms placebo in phase II trial, but is it enough?

The Emily Siddon Building - part of the National Health Innovation Campus at the University of Huddersfield - has been ...

Natera Inc. NTRA shares are up on Tuesday as the company announced promising results from a prospective study regarding its ...

When contextualized with the developments across all genitourinary [GU] malignancies, especially renal cell carcinoma and ...

Despite its enormous global burden, osteoarthritis has no licensed disease-modifying treatments, and available analgesics have moderate efficacy and substantial side-effects.1 The success of ...

Dental emergencies account for nearly 1 million emergency room visits annually among children under 15, according to the ...

The study met its primary endpoint of radiographic progression free survival, which was significantly prolonged with the ...

Confined space inspection in refineries is inherently dangerous. Robotics is now taking on that work, reducing the need for ...

Preclinical work has shown KRAS inhibition can delay cancer onset and extend survival in mice with pancreatic intraepithelial neoplasia lesions.